These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 12706864)
1. Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities. Jang YJ; Park KS; Chung HY; Kim HI Cancer Lett; 2003 May; 194(1):107-17. PubMed ID: 12706864 [TBL] [Abstract][Full Text] [Related]
2. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847 [TBL] [Abstract][Full Text] [Related]
3. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N; Poulaki V; Mitsiades C; Tsokos M Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151 [TBL] [Abstract][Full Text] [Related]
4. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines. Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785 [TBL] [Abstract][Full Text] [Related]
5. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Song JH; Bellail A; Tse MC; Yong VW; Hao C J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480 [TBL] [Abstract][Full Text] [Related]
6. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP. Jeon KI; Rih JK; Kim HJ; Lee YJ; Cho CH; Goldberg ID; Rosen EM; Bae I FEBS Lett; 2003 Jun; 544(1-3):246-51. PubMed ID: 12782325 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174 [TBL] [Abstract][Full Text] [Related]
9. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. Harper N; Hughes M; MacFarlane M; Cohen GM J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151 [TBL] [Abstract][Full Text] [Related]
11. Molecular requirements for the combined effects of TRAIL and ionising radiation. Marini P; Jendrossek V; Durand E; Gruber C; Budach W; Belka C Radiother Oncol; 2003 Aug; 68(2):189-98. PubMed ID: 12972315 [TBL] [Abstract][Full Text] [Related]
12. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161 [TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419 [TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A; Lam A; Datta R; Srivastava RK Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538 [TBL] [Abstract][Full Text] [Related]
17. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
18. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
19. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells. Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876 [TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]